title: Re: Prognostic Factors and Risk Groups in T1G3 Non-Muscle-Invasive Bladder Cancer Patients Initially Treated with bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients.
authors.forename: Sam S
authors.initials: SS
authors.lastname: Chang
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000627:therapeutic use; D001407:Bacillus; D015653:Cystectomy; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011379:Prognosis; D012189:Retrospective Studies; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine